Tyverb, i kombination med capecitabine, er indiceret til behandling af patienter med avanceret eller metastatisk brystkræft, hvis tumorer har overekspression af ErbB2 (HER2).
Tyverb, in combination with capecitabine, is indicated for the treatment of patients with advanced or metastatic breast cancer whose tumours overexpress ErbB2 (HER2).